Characteristics of CD8+T cell subsets in Chinese patients with chronic HIV infection during initial ART

被引:3
作者
Jiao, Yanmei [1 ]
Hua, Wei [1 ]
Zhang, Tong [1 ]
Zhang, Yonghong [1 ]
Ji, Yunxia [1 ]
Zhang, Hongwei [1 ]
Wu, Hao [1 ]
机构
[1] Capital Med Univ, Ctr Infect Dis, Beijing Youan Hosp, Beijing 100069, Peoples R China
来源
AIDS RESEARCH AND THERAPY | 2011年 / 8卷
关键词
ACTIVE ANTIRETROVIRAL THERAPY; T-CELLS; ACTIVATION; KINETICS; CHILDREN; DISEASE; VIREMIA; NAIVE; CD4; LYMPHOCYTES;
D O I
10.1186/1742-6405-8-15
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: CD8+ T cells may play an important role in protecting against HIV. However, the changes of CD8+ T cell subsets during early period of ART have not been fully studied. Methods: Twenty-one asymptomatic treatment-naive HIV-infected patients with CD4 T+ cells less than 350 cells/mu l were enrolled in the study. Naive, central memory(CM), effective memory(EM) and terminally differentiated effector (EMRA) CD8+ cell subsets and their activation and proliferation subsets were evaluated in blood samples collected at base line, and week 2, 4, 8 and 12 of ART. Results: The total CD8+ T cells declined and the Naive and CM subsets had a tendency of increase. Activation levels of all CD8+ T cell subsets except EMRA subset decreased after ART. However, proliferation levels of total CD8+ T cells, EMRA, EM and CM subsets increased at the first 4 weeks of ART, then decreased. Proliferation level of the naive cells decreased after ART. Conclusion: The changes of CD8+ T cell subsets during initial ART are complex. Our results display a complete phenotypical picture of CD8+ cell subsets during initial ART and provide insights for understanding of immune status during ART.
引用
收藏
页数:7
相关论文
共 28 条
[1]   Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence [J].
Alòs, L ;
Navarrete, P ;
Morente, V ;
Garcia, F ;
Garrido, M ;
Plana, M ;
Mozos, A ;
López, A ;
Gil, C ;
Pumarola, T ;
Caballero, M ;
Blanch, JL ;
Fumero, E ;
Miró, JM ;
Gallart, T ;
Gatell, JM ;
Campo, E .
MODERN PATHOLOGY, 2005, 18 (01) :127-136
[2]   Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover [J].
Anthony, KB ;
Yoder, C ;
Metcalf, JA ;
DerSimonian, R ;
Orenstein, JM ;
Stevens, RA ;
Falloon, J ;
Polis, MA ;
Lane, HC ;
Sereti, I .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 33 (02) :125-133
[3]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[4]   Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children [J].
Borkowsky, W ;
Stanley, K ;
Douglas, SD ;
Lee, S ;
Wiznia, A ;
Pelton, S ;
Yogev, R ;
McIntosh, K ;
Nachman, S .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01) :96-103
[5]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[6]   Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy [J].
Bouscarat, F ;
Levacher, M ;
Landman, R ;
Muffat-Joly, M ;
Girard, PM ;
Saimot, AC ;
Brun-Vézinet, F ;
Sinet, M .
AIDS, 1998, 12 (11) :1267-1273
[7]  
Ding Ying-ying, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P1176
[8]   T cell activation in HIV-seropositive Ugandans:: Differential associations with viral load, CD4+ T cell depletion, and coinfection [J].
Eggena, MP ;
Barugahare, B ;
Okello, M ;
Mutyala, S ;
Jones, N ;
Ma, YF ;
Kityo, C ;
Mugyenyi, P ;
Cao, H .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (05) :694-701
[9]   Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells [J].
Evans, TG ;
Bonnez, W ;
Soucier, HR ;
Fitzgerald, T ;
Gibbons, DC ;
Reichman, RC .
ANTIVIRAL RESEARCH, 1998, 39 (03) :163-173
[10]  
Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004